Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.
P53, cytoreductive surgery, survival, ovarian cancer
Copyright © David Engle, Hubert Fornalik, Traci Neff, Anna Button, K Collins, Amina Ahmed, David Bender, Susan Lutgendorf, Michael J. Goodheart, 2011
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.